1、 Product introduction |
Chinese Name | English Name | Declaration Type | Department | ReportableDosage Form | Declaration Progress | Strength | CAS |
美沙拉嗪 | Mupirocin | 5+4 | Gastroenterology | Tablets, enteric coated tablets, sustained-release granules, sustained-release tablets, suppositories, enteric coated tablets, enemas | Already accepted | 0.25mg、55mg、250mg、500mg、1g、60ml、4g | 89-57-6 |
【Indication】
Anti ulcerative colitis.
【Reportable Dosage Form &Strength】
Tablets: 0.25g, 55mg; enteric coated tablets: 250mg, 500mg 'sustained-release granules: 500mg; sustained-release tablets: 500mg; suppository: 1g, 500mg; enteric coated tablets: 500mg; enema: 60ml: 4g
【Development Progress】
Already accepted
2、Domestic Declaration
| Declaration Type | Reportable Dosage Form | Number of Declared Preparations | Number of Existing Preparation Enterprises |
| 5+4 | Tablet, enteric-coated tablet, sustained-release granule, sustained-release tablet, suppository, enteric-coated film tablet, enema | Enteric coated granules: 1 imported
Enteric coated sustained release tablets: 1 imported
Enteric coated tablets: 3 domestic
Enema fluid: 1 domestic, suppository: 2 imported
Slow release granules: 2 imported and 1 domestic
Sustained release tablets: 3 imported
Controlled release capsule: 1 domestic | Enteric coated tablets: 1 imported, 3 domestic
Enema fluid: 1 imported
Sustained release tablets: 1 imported
Suppository: 2 imported and 1 domestic
Slow release granules: 1 imported and 1 domestic |
![Brinzolamide 布林佐胺 CAS号：138890-62-7]( "Brinzolamide 布林佐胺 CAS号：138890-62-7")
Guangzhou Tosun Pharmaceutical Ltd
FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663
Tel: +86-20-66392521； Fax: +86-20-66392525